{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:32:13Z","timestamp":1781641933853,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Little is known about the potential use of the eosinophil count as a predictive marker of bloodstream infection. In this study, we aimed to assess the reliability of eosinopenia as a predictive marker of bloodstream infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study was performed in the outpatient department and general internal medicine department of a tertiary university hospital in Japan. A total of 189 adult patients with at least 2 sets of blood cultures obtained during the period January 1\u2013December 31, 2018, were included; those with the use of antibiotic therapy within 2\u2009weeks prior to blood culture, steroid therapy, or a history of haematological cancer were excluded. The diagnostic accuracies of each univariate variable and the multivariable logistic regression models were assessed by calculating the areas under the receiver operating characteristic curves (AUROCs). The primary outcome was a positive blood culture indicating bloodstream infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Severe eosinopenia (&lt;\u200924.4 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      ) alone yielded small but statistically significant overall predictive ability (AUROC: 0.648, 95% confidence interval (CI): 0.547\u20130.748,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), and only moderate sensitivity (68, 95% CI: 46\u201385%) and specificity (62, 95% CI: 54\u201369%). The model comprising baseline variables (age, sex), the C-reactive protein level, and neutrophil count yielded an AUROC of 0.729, and further addition of eosinopenia yielded a slight improvement, with an AUROC of 0.758 (P\u2009&lt;\u20090.05) and a statistically significant net reclassification improvement (NRI) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003). However, the integrated discrimination index (IDI) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.284) remained non-significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Severe eosinopenia can be considered an inexpensive marker of bloodstream infection, although of limited diagnostic accuracy, in a general internal medicine setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-4814-5","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T03:03:17Z","timestamp":1580353397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Eosinopenia as a diagnostic marker of bloodstream infection in a general internal medicine setting: a cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Takanobu","family":"Hirosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Nin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3788-487X","authenticated-orcid":false,"given":"Taro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"6","key":"4814_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/1469-0691.12180","volume":"19","author":"TJ Kirn","year":"2013","unstructured":"Kirn TJ, Weinstein MP. Update on blood cultures: how to obtain, process, report, and interpret. Clin Microbiol Infect. 2013;19(6):513\u201320.","journal-title":"Clin Microbiol Infect"},{"issue":"15","key":"4814_CR2","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and Management of Complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435\u201386.","journal-title":"Circulation"},{"issue":"9","key":"4814_CR3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267\u201384.","journal-title":"Clin Infect Dis"},{"key":"4814_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2334-5-35","volume":"5","author":"KB Laupland","year":"2005","unstructured":"Laupland KB, Church DL, Gregson DB. Blood cultures in ambulatory outpatients. BMC Infect Dis. 2005;5:35.","journal-title":"BMC Infect Dis"},{"key":"4814_CR5","doi-asserted-by":"crossref","unstructured":"Friedman ND, Braun T, Fallach N, Carmeli Y. Blood Culture Sampling Practices among Internal Medicine Inpatients. Clin Microbiol Infect Dis. 2017;2(1):1-6.","DOI":"10.15761\/CMID.1000120"},{"issue":"7","key":"4814_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.7326\/0003-4819-113-7-495","volume":"113","author":"David W. Bates","year":"1990","unstructured":"Bates DW CE, Goldman L, Lee TH. Predicting bacteremia in hospitalized patients. A prospectively validated model. Annals of internal medicine. 1990;113(7):6.","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"4814_CR7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.amjmed.2005.06.043","volume":"118","author":"Y Tokuda","year":"2005","unstructured":"Tokuda Y, Miyasato H, Stein GH, Kishaba T. The degree of chills for risk of bacteremia in acute febrile illness. Am J Med. 2005;118(12):1417.","journal-title":"Am J Med"},{"issue":"47","key":"4814_CR8","doi-asserted-by":"publisher","first-page":"48487","DOI":"10.1074\/jbc.R400025200","volume":"279","author":"S Black","year":"2004","unstructured":"Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279(47):48487\u201390.","journal-title":"J Biol Chem"},{"issue":"3","key":"4814_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1128\/JCM.20.3.317-319.1984","volume":"20","author":"RE Mccabe","year":"1984","unstructured":"Mccabe RE, Remington JS. C-reactive protein in patients with bacteremia. J Clin Microbiol. 1984;20(3):317\u20139.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"4814_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). Jama. 2016;315(8):801.","journal-title":"Jama"},{"issue":"2","key":"4814_CR11","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/cc6883","volume":"12","author":"K Abidi","year":"2008","unstructured":"Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA, et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care. 2008;12(2):R59.","journal-title":"Crit Care"},{"issue":"3","key":"4814_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1086\/380846","volume":"38","author":"MJ Setterberg","year":"2004","unstructured":"Setterberg MJ, Newman W, Potti A, Smego RA Jr. Utility of eosinophil count as predictor of bacteremia. Clin Infect Dis. 2004;38(3):460\u20131.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4814_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/0310057X1103900211","volume":"39","author":"BA Wibrow","year":"2011","unstructured":"Wibrow BA, Ho KM, Flexman JP, Keil AD, Kohrs DL. Eosinopenia as a diagnostic marker of bloodstream infection in hospitalised paediatric and adult patients: a case-control study. Anaesth Intensive Care. 2011;39(2):224\u201330.","journal-title":"Anaesth Intensive Care"},{"issue":"8","key":"4814_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042860","volume":"7","author":"R Terradas","year":"2012","unstructured":"Terradas R, Grau S, Blanch J, Riu M, Saballs P, Castells X, et al. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. Plos One. 2012;7(8):e42860.","journal-title":"Plos One"},{"issue":"3","key":"4814_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/23744235.2017.1388537","volume":"50","author":"S Karakonstantis","year":"2018","unstructured":"Karakonstantis S, Kalemaki D, Tzagkarakis E, Lydakis C. Pitfalls in studies of eosinopenia and neutrophil-to-lymphocyte count ratio. Infectious diseases. 2018;50(3):163\u201374.","journal-title":"Infectious diseases"},{"issue":"23","key":"4814_CR16","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency Care for Sepsis. N Engl J Med. 2017;376(23):2235\u201344.","journal-title":"N Engl J Med"},{"issue":"8","key":"4814_CR17","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749\u201355.","journal-title":"Crit Care Med"},{"issue":"1","key":"4814_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/clinids\/23.1.40","volume":"23","author":"MP Weinstein","year":"1996","unstructured":"Weinstein MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis. 1996;23(1):40\u20136.","journal-title":"Clin Infect Dis"},{"key":"4814_CR19","unstructured":"Wayne P. CLSI. Performance Standards for Antimicrobial Susceptibility Testing CLSI Supplement M100S. 26th ed. Clinical and Laboratory Standards Institute; 2016."},{"issue":"4","key":"4814_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jcrc.2010.03.002","volume":"25","author":"H Shaaban","year":"2010","unstructured":"Shaaban H, Daniel S, Sison R, Slim J, Perez G. Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital? J Crit Care. 2010;25(4):570\u20135.","journal-title":"J Crit Care"},{"issue":"2","key":"4814_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157\u201372 discussion 207-12.","journal-title":"Stat Med"},{"key":"4814_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"4814_CR23","doi-asserted-by":"crossref","unstructured":"Efron B TR. An introduction to the bootstrap: CRC press; 1994.","DOI":"10.1201\/9780429246593"},{"issue":"11","key":"4814_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.revmed.2016.02.018","volume":"37","author":"CE Lavoignet","year":"2016","unstructured":"Lavoignet CE, Le Borgne P, Slimani H, Forato M, Kam C, Kauffmann P, et al. Relevance of eosinopenia as marker of sepsis in the emergency department. Rev Med Interne. 2016;37(11):730\u20134.","journal-title":"Rev Med Interne"},{"key":"4814_CR25","unstructured":"Caffarini EM, DeMott J, Patel G, Lat I. Determining the Clinical Utility of an Absolute Procalcitonin Value for Predicting a Positive Culture Result. Antimicrob Agents Chemother. 2017;61, 5."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4814-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T19:12:29Z","timestamp":1611861149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4814-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4814"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4814-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.12730\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12730\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12730\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12730\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"29 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics committee of Dokkyo Medical University (No. R-20-18\u2009J). The committee approved participation of patients was obtained through an opt-out methodology. The patients consented to analysis of their medical records was not required. Any further permission from the hospital was not required. This was because of all data was obtained from usual clinical process.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}